$100 billion Tesla of the sky?

Meet Matt Pearson, a man who has a dream to make flying cars a reality for all of us – but what better place to trial the concept than a racetrack in the sky. His theory: competition drives progress.

Helping small businesses take positive climate actions

Together, we can make a louder noise and bring more people on the journey. The ecosystem we have created is open and easy. A small business can see what is relevant to them for their industry and size to help run the business so it looks after itself from an operational perspective and they can focus on the customer.

Two men watch a demonstration by another man holding a laptop computer.

Scarce tech talent vital to innovation and growth

If software and applications are the currency of the new economy, development teams are the market makers. Developers have gone from being a curiosity when I began my career to becoming a boardroom priority, especially as the pandemic and rapid digitisation that accompanied it has ratcheted up the urgency for business leaders.

Measuring customer satisfaction in store: Colorful buttons with smiley faces, on a white plastic device that enables customers to give feedback about their level of customer service satisfaction


They wrapped a Sydney tram in a giant Dovetail recruitment ad. They’re now up to 90 staff, with nine of them coming on board in the new San Francisco office. Ayers and Humphrey have retained a third ownership each.

Zoomo e-bike parked in front of Wise Sons Delicatessen in the Mission District, San Francisco, California.


The $108 million raised last financial year is being spent on software development and bringing their newest model, the Zoomo One, into production. The so-called “moped killer” will have a top speed of 45km/h.

bio tech lab

How venture capitalists shaped the modern biotech

Today, virtually all new drug discovery and early-stage drug development happens in small biotech firms, with Big Pharma hungrily waiting for the new drugs to boost their shrinking sales as the patents on their existing drugs inevitably expire.